Read Rethinking Life Sciences to find out the latest news and trends from across the pharmaceutical industry.
The highlight of this issue is our video interview with Clare Cutler, VP Oncology, Global Marketing at AbbVie shares her views on the challenges of combination treatments and the implications of therapy pricing. We also uncover the key trends in pharmaceuticals with some leading lights in KPMG’s Exceptional Women in Life Sciences programme.
A video interview with Clare Cutler, VP Oncology, at AbbVie discusses modern oncology and pursuing better patient outcomes.
Payers need big savings and R&D is costly. Is it time to shift from price-per-pill to charging for outcomes?
Participants in our Exceptional Women in Life Sciences programme share why they think user focus is a defining trend for the sector.
Our roadmap for big data beyond the hype – and how firms can build new capabilities
An emerging category finds its feet. So what’s next for nutraceuticals?